NEW ENTERPRISE ASSOCIATES 11 LP's Net Worth
$168 Million
Who is NEW ENTERPRISE ASSOCIATES 11 LP?
NEW ENTERPRISE ASSOCIATES 11 LP has an estimated net worth of $168 Million. This is based on reported shares across multiple companies, which include INNERWORKINGS INC, SUPERNUS PHARMACEUTICALS INC, AMICUS THERAPEUTICS INC, Tableau Software Inc, XOOM Corp, and AUDIENCE INC.
SEC CIK
NEW ENTERPRISE ASSOCIATES 11 LP's CIK is 0001243094
Past Insider Trading and Trends
2012 was NEW ENTERPRISE ASSOCIATES 11 LP's most active year for acquiring shares with 4 total transactions. NEW ENTERPRISE ASSOCIATES 11 LP's most active month to acquire stocks was the month of April. 2012 was NEW ENTERPRISE ASSOCIATES 11 LP's most active year for disposing of shares, totalling 12 transactions. NEW ENTERPRISE ASSOCIATES 11 LP's most active month to dispose stocks was the month of April. 2012 saw NEW ENTERPRISE ASSOCIATES 11 LP paying a total of $27,273,377.80 for 15,844,409 shares, this is the most they've acquired in one year. In 2012 NEW ENTERPRISE ASSOCIATES 11 LP cashed out on 31,840,882 shares for a total of $12,614,126.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AUDIENCE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -50.00% | -1.44M |
—
|
—
| 1.44M |
Nov 4
| |||
Form 4
| -32.73% | -1.40M |
—
|
—
| 2.88M |
Feb 15
| |||
Form 4
|
∞
| 4.28M |
—
|
—
| 4.28M |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SUPERNUS PHARMACEUTICALS INC (SUPN) Snapshot price: $33.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -50.00% | -3.82M |
—
|
—
| 3.82M |
Nov 11
| |||
Form 4
| -28.19% | -3.00M |
—
|
—
| 7.64M |
Jun 15
| |||
Form 4
|
∞
| 10.64M |
$5.00 |
—
| 10.64M |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMICUS THERAPEUTICS INC (FOLD) Snapshot price: $11.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.28% | 925.15K |
$5.70 | $5,273,377.80 | 4.58M |
Mar 7
| |||
Form 4
|
∞
| 3.66M |
$10.69 | -$96,120.00 | 3.66M |
Jun 5
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XOOM Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INNERWORKINGS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.94% | -500.00K |
—
|
—
| 4.53M |
Mar 28
| |||
Form 4
| -16.59% | -1.00M |
—
|
—
| 5.03M |
Mar 26
| |||
Form 4
| -7.02% | -455.36K |
$11.42 | -$5,199,163.87 | 6.03M |
Feb 29
| |||
Form 4
| -4.90% | -334.46K |
$11.40 | -$3,812,809.80 | 6.48M |
Feb 24
| |||
Form 4
| -4.32% | -308.06K |
$11.69 | -$3,602,152.45 | 6.82M |
Feb 22 - Feb 23
| |||
Form 4
| -12.30% | -1.00M |
—
|
—
| 7.13M |
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||